Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Open Text Corporation — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Open Text Corporation trades at $24.93 (market cap $6.05B). The key difference: Open Text Corporation is the larger of the two by market cap, and Open Text Corporation pays a 4.48% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Open Text Corporation for 24 Days on average.
| ORKA | OTEX | |
|---|---|---|
Market Cap | $5.08B | $6.05B |
Volume | 685,276 | 1,438,319 |
Sector | Health | Technology |
52-Week High | $113.08 | $39.69 |
52-Week Low | $26.19 | $20.01 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $4.21B | $11.07B |
Dividend Yield | — | 4.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OpenText (OTEX) trades at $24.95, up 3.18% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock's valuation appears attractive with a P/E of 9.68 and P/S of 1.19, while profitability metrics like a 73.74% gross margin and 16.19% ROE are robust. Recent corporate actions include a $1.0 billion senior secured notes offering and a partnership with Cohere to advance AI capabilities, signaling strategic debt management and growth initiatives.
The outlook is positive given improving fundamentals and analyst consensus, but risks include high debt levels and competitive pressures. The consensus price target of $28.30 suggests upside potential, supported by cloud revenue growth and cost discipline. Investors should weigh the discounted valuation against execution risks in a dynamic software market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
